ERTUGLIFLOZIN (Steglatro®)

Clinical Indication

Type 2 diabetes mellitus (for 18 years and over) as monotherapy

Comments

In line with NICE TA 572
Conditional on prescriber being competent to select appropriate patients

Date of classification

June 2019

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.